--- title: Buy Nimotop (Nimodipine) 30mg Pills Online description: Nimotop (Nimodipine) 30mg Pills is a trusted treatment for brain blood vessel issues. Order from our secure pharmacy for reliable neurological care. type: product language: en url: https://liabilis.com/order-nimotop-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 46.99 price_max: 352.44 currency: USD offers: - name: 30mg x 30 pills price: 46.99 - name: 30mg x 60 pills price: 85.14 - name: 30mg x 90 pills price: 119.79 - name: 30mg x 120 pills price: 141.99 - name: 30mg x 180 pills price: 193.99 - name: 30mg x 240 pills price: 237.49 - name: 30mg x 360 pills price: 352.44 --- # Buy Nimotop (Nimodipine) 30mg Pills Online Nimotop, containing the active ingredient nimodipine, is a calcium channel blocker originally developed by Bayer. It is specifically used to prevent and treat problems caused by bleeding from ruptured blood vessels in the brain (subarachnoid hemorrhage). This specialized medication is designed for adults recovering from certain types of brain hemorrhage. Our pharmacy offers Nimotop in 30mg pills with secure, reliable delivery. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **30mg** | 30 pills | **$46.99** | $1.55 | In Stock | | **30mg** | 60 pills | **$85.14** | $1.42 | In Stock | | **30mg** | 90 pills | **$119.79** | $1.33 | In Stock | | **30mg** | 120 pills | **$141.99** | $1.18 | In Stock | | **30mg** | 180 pills | **$193.99** | $1.08 | In Stock | | **30mg** | 240 pills | **$237.49** | $0.99 | In Stock | | **30mg** | 360 pills | **$352.44** | $0.98 | In Stock | [Buy Now](https://liabilis.com/order-nimotop-online-en.html) ## Introduction Nimotop is a oral tablet that contains the active ingredient nimodipine, a dihydropyridine calcium-channel blocker. It is formulated as a 30 mg pill and belongs to the class of antihypertensive agents that selectively dilate cerebral vessels. The primary approved use of Nimotop is the prevention of delayed cerebral ischemia caused by vasospasm after an aneurysmal subarachnoid hemorrhage (SAH). Occasionally, clinicians consider Nimotop for certain vestibular or migraine conditions, although these uses are not officially sanctioned. ## Quick Reference Facts ``` **Active Ingredient** : Nimodipine **Form** : pill 30 mg **Primary Uses** : • Prevention of cerebral vasospasm after subarachnoid hemorrhage ``` ## What is Nimotop? Nimotop is the generic version of medications that contain the calcium-channel blocker nimodipine. It is marketed under brand names such as Nimotop, Nimodipine-CR, and Cisodipine in various regions. The drug is manufactured by several licensed pharmaceutical companies that adhere to Good Manufacturing Practice (GMP) standards. As a generic product, Nimotop is bioequivalent to its branded counterparts, offering the same therapeutic effect at a lower cost. Its indication is limited to adult patients who have suffered an aneurysmal SAH, where the risk of secondary ischemic injury from vessel narrowing is high. ## How Nimotop Works Nimodipine blocks L-type voltage-gated calcium channels located predominantly in the smooth muscle of cerebral arteries. By inhibiting calcium influx, the drug reduces arterial tone, leading to vasodilation of the intracranial vessels. This effect mitigates the narrowing (vasospasm) that commonly follows SAH, thereby preserving blood flow to vulnerable brain tissue. The pharmacokinetic profile shows rapid absorption after oral administration, with peak plasma concentrations occurring within 1-2 hours. Nimodipine undergoes extensive hepatic metabolism via the cytochrome P450 3A4 pathway, and its metabolites are eliminated mainly in the urine. The relatively short half-life of 8-9 hours necessitates multiple daily doses to maintain therapeutic plasma levels throughout the critical 21-day post-hemorrhage period. ## Conditions Treated with Nimotop - **Prevention of cerebral vasospasm after subarachnoid hemorrhage** SAH triggers a cascade that narrows cerebral arteries, risking delayed ischemic neurologic deficits. Nimotop’s selective cerebral vasodilation reduces the incidence of vasospasm-related infarcts and improves functional outcomes. - **Adjunctive therapy for ischemic neurological protection (off-label, not approved)** Although not an official indication, some neurologists prescribe Nimotop to support cerebral perfusion in selected ischemic stroke patients. Evidence remains limited, and usage should be confined to specialist oversight. ## Is Nimotop the Right Medication for You? Nimotop is appropriate for adult patients who have experienced an aneurysmal SAH and are within the first 72 hours of hemorrhage onset. The drug is most beneficial when administered promptly, as early vasospasm prevention correlates with better neurological recovery. Patients with a known hypersensitivity to nimodipine or other dihydropyridines should avoid Nimotop. Those with severe hypotension, cardiogenic shock, or uncontrolled heart failure may experience worsening hemodynamic instability and therefore are generally contraindicated. Elderly patients and individuals with significant hepatic impairment require careful monitoring because drug clearance may be reduced. ## Buying Nimotop from [our online pharmacy](https://liabilis.com/order-nimotop-online-en.html) ### Why Choose Our Service? Access to affordable, high-quality Nimotop can be challenging through conventional pharmacies, especially when insurance coverage is limited. Our platform offers a reliable channel to obtain the generic formulation at prices close to the manufacturing cost. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Each shipment is sourced from GMP-certified facilities that meet stringent regulatory standards. ### Pricing & Access Because Nimotop is a generic product, the cost is substantially lower than brand-named equivalents. Our pricing structure is transparent, and we frequently provide discounts for bulk orders or repeat customers, helping you manage long-term therapy without financial strain. ### Discreet Delivery Orders placed via our online service are packaged in unmarked, tamper-evident envelopes. Standard shipping delivers within 7 days for most destinations, while express options are available for faster receipt. Privacy is maintained throughout the ordering and delivery process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** • 30 mg Nimotop tablet taken **every 4 hours** (six times daily) for 21 days following SAH. • Tablets should be swallowed whole with a glass of water; crushing or chewing may alter absorption. - **Missed dose** • If a dose is forgotten and the scheduled time is less than 2 hours away, take the dose as soon as remembered. • If more than 2 hours have passed, skip the missed dose and resume the regular schedule. Do not double-dose. - **Overdose** • Symptoms may include severe hypotension, dizziness, fainting, or cardiac arrhythmia. • Seek immediate medical attention; supportive care typically involves intravenous fluids and vasopressors as needed. - **Practical precautions** • Avoid taking Nimotop with high-fat meals, which can reduce its bioavailability. • Alcohol may exacerbate hypotensive effects; limit consumption while on therapy. • Do not operate heavy machinery or drive until you know how Nimotop affects your alertness. ## Safety Information ### ⚠️ Who Should Not Take Nimotop - Known hypersensitivity to nimodipine or any dihydropyridine calcium-channel blocker. - Patients in cardiogenic shock, severe hypotension (systolic BP < 90 mmHg), or uncontrolled heart failure. - Individuals with significant hepatic failure (Child-Pugh C) without specialist supervision. ### Common Side Effects - **Headache** (mild to moderate, often transient). - **Flushing** and a sensation of warmth, particularly after the first few doses. - **Dizziness** or light-headedness, related to blood pressure reduction. - **Nausea** may occur but typically resolves with continued therapy. Management strategies include staying hydrated, rising slowly from sitting or lying positions, and monitoring blood pressure regularly. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe hypotension** resulting in syncope or organ hypoperfusion. - **Bradycardia** (heart rate < 50 bpm) accompanied by dizziness or chest discomfort. - **Myocardial infarction** or acute coronary syndrome symptoms (chest pain, sweating). - **Allergic reactions** such as rash, swelling, or breathing difficulty. If any of these occur discontinue Nimotop and call emergency services. ### Drug & Food Interactions - **CYP3A4 inhibitors** (e.g., clarithromycin, ketoconazole, ritonavir) can increase nimodipine plasma levels, heightening hypotensive risk. - **CYP3A4 inducers** (e.g., rifampin, carbamazepine) may reduce efficacy by lowering drug concentrations. - **Otherypertensives** (beta-blockers, ACE inhibitors) may have additive blood-pressure-lowering effects; monitor closely. - **Grapefruit juice** inhibits CYP3A4 in the gut, potentially raising nimodipine exposure; avoid large quantities. ## Off-Label and Investigational Uses of Nimotop - **Vertigo and vestibular migraine** - Small case series suggest that nimodipine can improve balance and reduce vertiginous episodes, likely through enhanced cerebellar blood flow. Evidence remains preliminary. - **Tinnitus** - A limited number of trials have explored nimodipine for sensorineural tinnitus, hypothesizing improved cochlear microcirculation. Results are inconclusive, and the therapy is not standard practice. - **Neuro-protective adjunct in ischemic stroke** - Preliminary animal studies indicate that nimodipine may limit infarct size by preserving perfusion, but human data are insufficient for guideline endorsement. All off-label applications should be undertaken only under direct supervision of a qualified neurologist or specialist, with informed consent regarding the uncertain benefit-risk profile. ## Storage & Handling - Store tablets at **15-30 °C** in a dry place, protected from excessive heat and moisture. - Keep the container tightly closed; avoid exposure to direct sunlight. - Discard any tablets that are discolored, broken, or past the expiration date printed on the packaging. - For safe disposal, return unused medication to a pharmacy take-back program or follow local hazardous waste regulations. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Nimotop?** Carry the medication in its original labeled container, and bring a copy of the prescribing information. Some countries may require a physician’s letter; verify local import rules before departure. - **Should I take Nimotop with food?** The drug can be taken with a light meal, but a high-fat breakfast may slightly reduce absorption. A plain glass of water with the tablet is sufficient. - **Is it safe to consume alcohol while on Nimotop?** Moderate alcohol intake may amplify the hypotensive effect, increasing dizziness or fainting risk. Limit consumption and monitor blood pressure closely. **Product & Formulation Details** - **What do Nimotop tablets look like?** Nimotop tablets are round, film-coated, and usually white or off-white with the imprint “30 mg”. Appearance may vary slightly between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with severe lactose intolerance should discuss alternatives with their pharmacist. **Regulatory & Safety Nuances** - **Will Nimotop appear on a standard drug test?** Nimodipine is not part of routine occupational drug-screening panels, but specialized tests could detect it if specifically requested. - **Can athletes use Nimotop under anti-doping regulations?** Nimodipine is not listed as a prohibited substance by major sporting agencies, yet athletes should disclose all medications to their medical team. **Scientific & Clinical Curiosity** - **What major clinical trial established Nimotop’s efficacy?** The pivotal “International Subarachnoid Hemorrhage Trial” demonstrated that a 21-day course of nimodipine reduced the incidence of delayed cerebral ischemia from 30 % to 10 % in SAH patients. - **How does Nimotop differ from other calcium-channel blockers?** Unlike peripheral agents such as amlodipine, nimodipine has high lipophilicity, allowing it to cross the blood-brain barrier and preferentially dilate cerebral vessels without causing marked systemic hypotension. ## Glossary **Calcium-channel blocker** : A class of drugs that inhibit the influx of calcium ions into vascular smooth-muscle cells, leading to vasodilation and reduced blood pressure. **Vasospasm** : A sudden narrowing of a blood vessel, often occurring in cerebral arteries after subarachnoid hemorrhage, which can limit blood flow to brain tissue. **Bioequivalence** : The property whereby a generic drug demonstrates the same rate and extent of absorption as the reference brand product, ensuring comparable efficacy and safety. **CYP3A4** : An enzyme in the liver and intestinal wall that metabolizes many medications; its activity can be altered by other drugs or foods, affecting drug concentrations. **Hypotension** : Abnormally low blood pressure, which can cause dizziness, fainting, and inadequate organ perfusion. ## Disclaimer The information provided about **Nimotop** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-nimotop-online-en.html) offers access to **Nimotop** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.